Recombinant Tissue Plasminogen Activator Increases Blood-Brain Barrier Disruption in Acute Ischemic Stroke: An MR Imaging Permeability Study

BACKGROUND AND PURPOSE: Although thrombolytic therapy (recombinant tissue plasminogen activator [rtPA]) represents an important step forward in acute ischemic stroke (AIS) management, there is a clear need to identify high-risk patients. The purpose of this study was to investigate the role of quant...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:AJNR Am J Neuroradiol
Autors principals: Kassner, A., Roberts, T.P.L., Moran, B., Silver, F.L., Mikulis, D.J.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Neuroradiology 2009
Matèries:
Brain
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7051295/
https://ncbi.nlm.nih.gov/pubmed/19661169
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3174/ajnr.A1774
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars